Acute infective conjunctivitis in primary care: who needs antibiotics? An individual patient data meta-analysis
Authors:
- Rafael PereraRPRafael Perera
- Hazel EverittHEHazel Everitt
- Henk van WeertHWHenk van Weert
- Remco RietveldRRRemco Rietveld
- Paul GlasziouPGPaul Glasziou
- Peter RosePRPeter Rose
- 1 September 2011
- journal article
- research article
- Published by Royal College of General Practitioners in British Journal of General Practice
- Vol. 61 (590) , e542-e548
Abstract
Acute infective conjunctivitis is a common problem in primary care, traditionally managed with topical antibiotics. A number of clinical trials have questioned the benefit of topical antibiotics for patients with acute infective conjunctivitis. To determine the benefit of antibiotics for the treatment of acute infective conjunctivitis in primary care and which subgroups benefit most. An individual patient data meta-analysis. Relevant trials were identified and individual patient data gathered for meta-analysis and subgroup analysis. Three eligible trials were identified. Individual patient data were available from all primary care trials and data were available for analysis in 622 patients. Eighty per cent (246/308) of patients who received antibiotics and 74% (233/314) of controls were cured at day 7. There was a significant benefit of antibiotics versus control for cure at seven days in all cases combined (risk difference 0.08, 95% confidence interval (CI) = 0.01 to 0.14). Subgroups that showed a significant benefit from antibiotics were patients with purulent discharge (risk difference 0.09, 95% CI = 0.01 to 0.17) and patients with mild severity of red eye (risk difference 0.10, 95% CI = 0.02 to 0.18), while the type of control used (placebo drops versus nothing) showed a statistically significant interaction (P=0.03). Acute conjunctivitis seen in primary care can be thought of as a self-limiting condition, with most patients getting better regardless of antibiotic therapy. Patients with purulent discharge or a mild severity of red eye may have a small benefit from antibiotics. Prescribing practices need to be updated, taking into account these results.Keywords
This publication has 27 references indexed in Scilit:
- Relative impact of clinical evidence and over-the-counter prescribing on topical antibiotic use for acute infective conjunctivitisBritish Journal of General Practice, 2009
- Allergic rhinoconjunctivitis and differential diagnosis of the red eyeAllergy and Asthma Proceedings, 2008
- Clinical Cure of Bacterial Conjunctivitis with Azithromycin 1%: Vehicle-Controlled, Double-Masked Clinical TrialAmerican Journal of Ophthalmology, 2008
- A randomised controlled trial of management strategies for acute infective conjunctivitis in general practiceBMJ, 2006
- Chloramphenicol treatment for acute infective conjunctivitis in children in primary care: a randomised double-blind placebo-controlled trialThe Lancet, 2005
- Acute red eyePostgraduate Medicine, 1997
- Current Practice: Diagnosis and Treatment in Primary HealthcareAllergy, 1995
- Acute conjunctivitis in childhoodThe Journal of Pediatrics, 1993
- Eye disease at a community health centre.BMJ, 1986
- Etiology of acute conjunctivitis in childrenThe Journal of Pediatrics, 1981